BNTX - BioNTech SE - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BNTX is currently covered by 16 analysts with an average price target of $149.27. This is a potential upside of $39.25 (35.68%) from yesterday's end of day stock price of $110.02.

BioNTech SE's activity chart (see below) currently has 162 price targets and 188 ratings on display. The stock rating distribution of BNTX is 28.4% HOLD, 65.43% BUY and 6.17% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 53.9% with an average time for these price targets to be met of 54 days.

Highest price target for BNTX is $171.44, Lowest price target is $110, average price target is $131.39.

Most recent stock forecast was given by TAZEEN AHMAD from BAML on 16-Jul-2025. First documented stock forecast 04-Nov-2019.

Currently out of the existing stock ratings of BNTX, 23 are a HOLD (28.4%), 53 are a BUY (65.43%), 5 are a SELL (6.17%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$126

$15.98 (14.52%)

$150

3 days ago
(16-Jul-2025)

7/13 (53.85%)

$13.51 (12.01%)

49

Buy

$133

$22.98 (20.89%)

$132

9 days ago
(10-Jul-2025)

2/6 (33.33%)

$19.08 (16.75%)

25

Buy

$138

$27.98 (25.43%)

$138

24 days ago
(25-Jun-2025)

14/35 (40%)

$33.2 (31.68%)

69

Hold

$110

$-0.02 (-0.02%)

$137

1 months 20 days ago
(29-May-2025)

5/9 (55.56%)

$9.75 (9.73%)

77

Hold

$116

$5.98 (5.44%)

$122

1 months 27 days ago
(22-May-2025)

10/11 (90.91%)

$16.93 (17.09%)

40

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BNTX (BioNTech SE) average time for price targets to be met?

On average it took 54 days on average for the stock forecasts to be realized with a an average price target met ratio 53.9

Which analyst has the current highest performing score on BNTX (BioNTech SE) with a proven track record?

SHANSHAN XU

Which analyst has the most public recommendations on BNTX (BioNTech SE)?

Shanshan Xu has 5 price targets and 3 ratings on BNTX

Which analyst is the currently most bullish on BNTX (BioNTech SE)?

Olga Smolentseva with highest potential upside - $342.36

Which analyst is the currently most reserved on BNTX (BioNTech SE)?

Chris Shibutani with lowest potential downside - -$0.02

BioNTech SE in the News

RFK Jr. sued by doctor, health groups over changes to COVID shot recommendations

[President Trump Attends MAHA Commission Event At White House] Chip Somodevilla/Getty Images News * HHS Secretary Robert F. Kennedy Jr. is being sued by various groups representing physicians and public health workers over his decision to change recommendations for COVID-19 vaccines for healthy children and pregnant women. * “Unless the secretary’s baseless and uninformed policy...

Barbara Weber, M.D., Elected to ITM Supervisory Board

Garching / Munich, Germany, April 09, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced the election of Barbara Weber, M.D., to its Supervisory Board, effective May 01, 2025. The election occurred at ITM’s Extraordinary General Meeting. Dr. Weber is the President, Chief Executive Officer and Founder of Tango...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?